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Advances in human genetics in recent years have largely been driven by next-generation sequencing (NGS); however, the discovery of
disease-related genemutations has been biased toward the exome because the large and very repetitive regions that characterize the non-
coding genome remain difficult to reach by that technology. For autosomal-dominant spinocerebellar ataxias (SCAs), 28 genes have been
identified, but only five SCAs originate from non-coding mutations. Over half of SCA-affected families, however, remain without a
genetic diagnosis. We used genome-wide linkage analysis, NGS, and repeat analysis to identify an (ATTTC)n insertion in a polymorphic
ATTTTrepeat inDAB1 in chromosomal region 1p32.2 as the cause of autosomal-dominant SCA; this region has been previously linked to
SCA37. The non-pathogenic and pathogenic alleles have the configurations [(ATTTT)7–400] and [(ATTTT)60–79(ATTTC)31–75(ATTTT)58–90],
respectively. (ATTTC)n insertions are present on a distinct haplotype and show an inverse correlation between size and age of onset. In
theDAB1-oriented strand, (ATTTC)n is located in 5
0 UTR introns of cerebellar-specific transcripts arisingmostly during human fetal brain
development from the usage of alternative promoters, but it is maintained in the adult cerebellum. Overexpression of the transfected
(ATTTC)58 insertion, but not (ATTTT)n, leads to abnormal nuclear RNA accumulation. Zebrafish embryos injected with RNA of the
(AUUUC)58 insertion, but not (AUUUU)n, showed lethal developmental malformations. Together, these results establish an unstable
repeat insertion in DAB1 as a cause of cerebellar degeneration; on the basis of the genetic and phenotypic evidence, we propose this
mutation as the molecular basis for SCA37.Introduction
Spinocerebellar ataxias (SCAs) are a group of clinically and
genetically very heterogeneous diseases, usually character-
ized by adult onset of progressive gait, limb, and speech
ataxia caused by loss of cerebellar neurons.1,2 The esti-
mated prevalence of autosomal-dominant SCAs varies
considerably in different world regions from 1.6 to 5.6
out of 100,000 inhabitants;1,3 Machado-Joseph disease
(MJD; also known as SCA3 [MIM: 109150]) is the most
frequent in Portugal and worldwide, but a definite genetic
diagnosis is still lacking for more than half of the families
affected by these neurodegenerative diseases.1,4
Currently 28 genes are known to harbor mutations
causing SCA pathology. Seven of these are CAG repeat ex-
pansions that encode aberrant polyglutamine tracts in the
protein products, rendering them toxic. Point mutations,
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types.5–7 Unstable repeat expansions in non-coding re-
gions of protein-encoding genes have been reported only
in five SCAs.8
The disease mechanism(s) associated with non-coding
repeat expansions remained obscure until the concept
emerged that RNA transcripts harboring expanded repeats
were toxic in myotonic dystrophy type 1 (DM1 [MIM:
160900]).9,10 RNA-associated pathogenesis was subse-
quently identified in other neurodegenerative diseases also
caused by non-coding expanded repeats, such as myotonic
dystrophy 2 (DM2 [MIM: 602668]), fragile X tremor/ataxia
syndrome (FXTAS [MIM: 300623]), HD-like disease type 2
(HDL2 [MIM: 606438]), frontotemporal dementia and/or
amyotrophic lateral sclerosis (FTDALS [MIM: 105550]), and
several SCAs caused by non-coding repeat mutations.8,10,11
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(MIM: 614153), and SCA31 (MIM: 117210), the untrans-
lated RNA repeat accumulates in affected brain tissue and
correlates with the pathogenesis.1,10,12–14 SCA8 is associ-
ated with bidirectional transcription of a CTG/CAG repeat
located in the UTR of ATXN8OS (MIM: 603680) and in a
short open reading frame in the overlapping ATXN8
(MIM: 613289).15 In SCA10, SCA31, and SCA36, very large
intronic penta- or hexanucleotide repeats are found in
ATXN10 (MIM: 611550), TK2 (MIM: 188250) and BEAN1
(MIM: 612051), and NOP56 (MIM: 614154), respec-
tively.12–14,16 Studies on RNA-mediated pathogenesis
point toward a complex combination of different effects,
including aberrant transcript expression and processing
and the formation of RNA aggregates in affected cells and
tissues, which are also detected in cell and animal models
that overexpress the repeat.8,11,17–19
Here, we describe a SCA in three large Portuguese fam-
ilies identified during a population-based survey of hered-
itary ataxias in Portugal.3 The affected individuals from
these families share a pure cerebellar ataxia phenotype
and, distinctively, onset of dysarthria in late adolescence
to adulthood. In this study, we mapped this SCA by
genome-wide linkage analysis of the families and identi-
fied a pathological (ATTTC)n repeat insertion in the non-
coding region of DAB1 (DAB1, reelin adaptor protein
[MIM: 603448]) in chromosomal region 1p32.2, which
overlaps the SCA37 linkage region (MIM: 615945).20 Given
the significant death caused by injection of the RNA repeat
insertion in zebrafish, we suggest that RNA-mediated
toxicity could be one pathogenic mechanism implicated
in this SCA.Subjects and Methods
Subjects
Families were ascertained during a nationwide, population-based,
systematic survey of hereditary ataxias and spastic paraplegias
performed in Portugal from 1994 to 2004.3 Affected individuals
were referred for diagnostic purposes to the authorized Center
for Predictive and Preventive Genetics (CGPP) at the Institute for
Molecular and Cell Biology; they were tested for mutations in
genes associated with SCA1, DRPLA, SCA2, MJD (SCA3), SCA6,
SCA7, SCA8, SCA10, SCA12, SCA14, and SCA17. This study used
the de-identified, previously collected DNA samples that were
stored at the CGPP biobank, as well as anonymized samples
from the Fundacio´n Pu´blica Galega de Medicina Xeno´mica and
from the Montre´al Neurological Institute at McGill University.
For the study of relevant polymorphisms in the Portuguese popu-
lation, anonymized DNA samples were obtained from both dried-
blood spots from the public health laboratory newborn screening
program and internal lab control samples. For skin biopsies,
informed written consent was given for participation in this study,
which was approved by the health ethics board of the Hospital
Prof. Doutor Fernando Fonseca.
Genotyping and Linkage Analysis
DNA samples from 65 individuals from three Portuguese families
were hybridized to Affymetrix GeneChip Human Mapping 10K88 The American Journal of Human Genetics 101, 87–103, July 6, 201Array Xba 142 2.0 according to the manufacturer’s recommenda-
tions. Each individual genotype was obtained with GeneChip
DNA Analysis Software 3.0. After batch import of pedigree
and sample information, data were checked for Mendelian
errors. The file obtained was imported into ALOHOMORA21 and
analyzed with PEDSTATS22 for a check of the consistency of the
pedigree and identification of uninformative and/or mistyped
SNPs for removal from the dataset. SNPs were reformatted as
individual chromosomes for linkage in Merlin.23 Multipoint
linkage analysis was performed with a parametric model assuming
an autosomal-dominant mode of inheritance, a disease-allele fre-
quency of 0.0001, and 95% penetrance.
Short tandem repeat (STR) markers from chr1: 51,245,557–
59,958,568 (UCSC Genome Browser build hg19) were analyzed
in families by PCR. Allele sizes were assessed by an ABI3730xl
DNA Analyzer with GeneMapper software v.4.0 (Applied
Biosystems).Mutation Screening
Mutation screening was performed in affected individuals and un-
affected relatives by Sanger sequencing of exon and exon-intron
boundaries and by NGS. NGS was carried out in six affected indi-
viduals (II.9 and III.1 from family M, II.1 and III.6 from family G,
and II.7 and III.5 from family R) and four unaffected relatives
(II.10 from family M, II.6 and III.5 from family G, and II.3 from
family R) at the sequencing facility of the Fundacio´n Pu´blica
Galega de Medicina Xenomica. Enrichment was performed with
SureSelect Target Enrichment (Agilent Technologies) targeting
3.4 Mb of genomic sequence at chr1: 55,800,000–59,200,000
(hg19). Each genomic library was sequenced with a SOLiD
5500xl system (Life Technologies) as paired-end reads (75 þ
35 bp). Reads were aligned to the reference genome (hg19) with
SOLiD BioScope software v.1.3.0, and then variants were called
with Genome Analysis Toolkit v.2.1.24 In the ten individuals
analyzed by NGS, the number of reads matching the target region
ranged from 2,366,593 to 3,444,594. 77.7%–84.12% of the target
region was covered at least 203, whereas 92.2%–93.4% was
covered at least 53; the average depth of coverage ranged from
35.113 to 51.293. Variant calling required at least 63 minimum
depth of coverage. The next variant-filtering steps required that
the variant be (1) heterozygous and (2) absent (or with a frequency
below 0.01) from public databases (dbSNP135 and 1000 Genomes
Project; February 2012).
Screening for repeat expansions was performed by standard
PCR analysis in a family branch from each of the M, G and R ped-
igrees. Approximate allele size was assessed in 2% agarose gel.
Non-polymorphic repeats were confirmed by PCR amplification
with a 6-FAM labeled reverse primer and detected on an ABI3730xl
DNA Analyzer.Southern Blot Analysis
Genomic DNA (10 mg) was digested with XbaI (Fermentas Life Sci-
ences). Digestion products were separated by electrophoresis on a
0.8% agarose gel, denatured with 0.4 M NaOH, and transferred in
103 saline sodium citrate (SSC) onto a Hybond-Nþ nylon mem-
brane (GE Healthcare) with a vacuum blotter (Bio-Rad). DNA
was immobilized onto the membrane by UV cross-linking. The
hybridization probe was synthesized from genomic DNA by PCR
with HotStarTaq Master Mix Kit (QIAGEN) and primers SB24F
and SB24R (Table S1 and Figure 2D). The probe was labeled with
[a-32P]-dCTP with a specific activity of 3000Ci/mmol with the7
Prime It II Random Primer Labeling Kit (Agilent Technologies).
Hybridization was carried out overnight at 65C, and the signal
was detected by X-ray film exposure or by phosphor storage screen
and digital image acquisition on a Typhoon imaging system (GE
Healthcare).
PCR Amplification and Sequencing of Pentanucleotide
Repeat Alleles
Short pentanucleotide repeats were analyzed by standard PCR
with primers 24F and 24R (Table S1 and Figure 2D) with
HotStarTaqMaster Mix Kit (QIAGEN). PCR products were purified,
and repeat size was assessed by Sanger sequencing. Large pentanu-
cleotide repeat alleles were analyzed by long-range PCR with
200 ng DNA, 0.3 mM primers ALU24F and ALU24R (Table S1),
200 mM dNTPs, 1.4 mM MgCl2, 60 mM Tris-SO4 (pH 9.1),
18 mM (NH4)2SO4, 2 mM MgSO4, and 1 mL of Elongase Enzyme
Mix (Invitrogen) in 50 mL. After 3 min at 94C, DNA samples un-
derwent ten cycles of amplification (94C for 30 s and 62C for
7 min) followed by an additional 30 cycles (94C for 30 s and
62C for 7 min with 20 s increments per cycle). PCR products
were separated by electrophoresis in 1% agarose gels, DNAwas ex-
tracted from the gel, and the number of repeat units and insertion
composition were determined by Sanger sequencing with internal
primers 24F and 24R4 (Table S1).
Repeat-Primed PCR for (ATTTC)n Insertion Alleles
The repeat insertion sequence was amplified by repeat-primed
PCR (RP-PCR) with primers 24R, FLAG, and RP-TTCAT (Table
S1). Reverse primer 24R was a 6-FAM-labeled locus-specific primer,
RP-TTCAT was a repeat insertion-specific primer with a DNA tail
sequence at the 50 end, and reverse primer FLAG contained the
same 50 tail sequence as RP-TTCAT. PCR was performed with
100 ng genomic DNA, 0.4 mM primer 24F and primer FLAG, and
0.04 mMprimer RP-TTCATwith HotStarTaqMasterMix (QIAGEN).
The initial RP-PCR step was at 95C for 15 min and was followed
by 35 cycles (95C for 45 s, 58C for 30 s, and 72C for 2 min
with 20 s increments per cycle). Products of RP-PCR were detected
on an ABI3730xl DNA Analyzer.
Pentanucleotide Repeat Cloning
For cloning, PCR amplification of normal alleles with 7–139
ATTTTs and the pathological (ATTTT)57(ATTTC)58(ATTTT)73 inser-
tion (abbreviated ins(ATTTC)58) allele was carried out with primers
flanking the Alu sequence, containing restriction sites for EcoRI
and NotI (Table S1). PCR products were separated by agarose gel
electrophoresis, and DNA was extracted with the QIAquick
Gel Extraction Kit (QIAGEN), ligated into pCDH-CMV-MCS-EF1-
GFP-T2A-Puro (System Biosciences), and transformed into the
DH5a E. coli strain. Plasmid DNA was isolated with the QIAGEN
PlasmidMidi Kit, and the insert sequencewas confirmed by Sanger
sequencing.
Cell Culture
Primary cultures of fibroblasts, established from skin biopsies, and
HEK293T cells were cultured in DMEM with 10% fetal bovine
serum at 37C with 5% CO2.
Analysis of Gene Expression
For RT-PCR, RNA first-strand cDNA was synthesized with Super-
Script III First-Strand Synthesis SuperMix (Invitrogen) from total
human cerebellum RNA (Clontech).The ACell Transfection and RNA Fluorescence In Situ
Hybridization Analysis
For RNA in situ hybridization, a digoxigenin 30- and 50-labeled
locked nucleic acid (LNA) probe (Exiqon) was synthesized to
contain the sequence (TGAAA)5TGA, predicted to hybridize to
(AUUUC)n. HEK293T cells were transfected with the plasmid
N(ATTTT)7, N(ATTTT)139, or ins(ATTTC)58 with jetPRIME transfec-
tion reagent (Polyplus-transfection). 48 hr after transfection, cells
were fixed in 4% paraformaldehyde. Permeabilization was per-
formed in 0.2% Triton in PBS for 10 min. After this, the coverslips
were incubated in prehybridization solution (50% formamide,
10% dextran sulfate, 23 SSC, 50 mM sodium phosphate buffer,
10 mM ribonucleosyde vanadyl complex, and 100 mg/mL yeast
tRNA) for 20min at 60C. The LNA probewas used at a working so-
lution of 40 nM after dilution in prehybridization buffer and incu-
bated for 2 hr at 60C. This was followed by several washes at room
temperature (5 min of 23 SSC and 0.1% Tween 20) and at 60C
(10 min of 0.23 SSC). Coverslips were blocked with 5% BSA in
PBS with Tween 20 for 30 min and incubated overnight with
anti-digoxigenin-rhodamine antibody (Roche Diagnostics). They
were counterstained with DAPI. Fluorescence in situ hybridization
(FISH) signalswere scoredwithaLeicaMicrosystems SP5 II confocal
microscopewith a633glycerol objective. ForDNaseorRNase treat-
ment, before prehybridization, coverslipswere incubated for 1hr at
37Cwith 200U/mLDNaseI or 100 mg/mLRNase A (Thermo Fisher
Scientific). After acquisition, images were analyzed with Fiji.25
Protein Analysis
Total protein extracts were prepared from cultured cells or frozen
human cerebellum in radioimmunoprecipitation assay solution
containing a cocktail of protease and phosphatase inhibitors. For
cells, direct lysis was performed on ice by scrapping. Tissue was
homogenized on ice, sonicated, incubated on ice for 30 min,
and centrifuged. Protein lysates were resolved by standard PAGE
and transferred onto a nitrocellulosemembranewith a rapid trans-
fer system (Bio-Rad). Membranes were incubated overnight with
a rabbit polyclonal anti-DAB1 antibody (sc-13981, Santa Cruz
Biotechnology, at 1:500 dilution) at 4C, incubated for 1 hr
with a horseradish peroxidase (HRP)-conjugated antibody, and
analyzed for signal detection with an enhanced chemilumescent
HRP substrate (SuperSignal West Pico). Signal acquisition was per-
formed digitally with a ChemiDoc XRSþ (Bio-Rad).
In Vitro Synthesis of RNA
Two complementary oligonucleotides were used for cloning a
T7 promoter in the pCDH-CMV-MCS-EF1-GFP-T2A-Puro vector
harboring the normal N(ATTTT)7 and N(ATTTT)139 alleles and
the pathological ins(ATTTC)58 allele. Oligonucleotides had over-
hanging sequences compatible with XbaI and EcoRI, restriction
sites used for cloning (Table S1). A mix of T7A and T7B oligonucle-
otides were denatured at 95C for 5 min, annealed at room tem-
perature, and used in the pCDH-CMV-MCS-EF1-GFP-T2A-Puro
ligation. After cloning, T7-pCDH-CMV-MCS-EF1-GFP-T2A-Puro
vectors were linearized with NotI and purified by phenol-chloro-
form, and RNA was transcribed in vitro with T7 RNA polymerase.
Cas9 mRNA was used as control RNA for the injections and was
transcribed in vitro as previously described.26
Zebrafish RNA Microinjection
All zebrafish (Danio rerio) experiments complied with standard
animal care guidelines and national legislation for animalmerican Journal of Human Genetics 101, 87–103, July 6, 2017 89
Figure 1. Pedigrees of SCA-Affected Families and STR Haplotypes
Pedigree structures of the three families used for genome-wide linkage analysis and the corresponding individual genotypes and penta-
nucleotide repeat configuration. Below are the disease haplotypes from selected affected individuals, identified by pedigree number, for
(legend continued on next page)
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experimentation. Zebrafish were crossed for the generation of em-
bryos for RNA injections; 5 nL in-vitro-synthesized RNA for each
of the normal N(ATTTT)7 and N(ATTTT)139 alleles and the patho-
logical ins(ATTTC)58 allele and control RNA was microinjected in
the yolk of 1- to 2-cell stage zebrafish embryos27 at a concentration
of 100 ng/mL. Each RNA sequencewasmicroinjected three times in
at least 200 embryos per injection. Embryos were raised at 28C in
E3 medium and observed at 6 and 24 hr postfertilization (hpf).
Embryos were anesthetized by the addition of tricaine (ethyl
3-aminobenzoate; Sigma) to the E3 medium, and phenotypes
were documented at 24 hpf with a stereomicroscope Leica
M205FA (Leica Microsystems) on the imaging acquisition system
Orca Flash 4.0LT (Hamamatsu Photonics). For analysis of lethality
rate and normal developmental, the statistical significance was
assessed with the c2 test.Results
Mapping SCA to Chromosomal Region 1p32.2
We studied three large Portuguese families affected by
an unknown genetic type of autosomal-dominant SCA
with adult onset and characterized by dysarthria as the
first symptom in most affected individuals (Figure 1). All
affected subjects had a similar clinical presentation consist-
ing of progressive pure cerebellar ataxia starting in their late
teens to early 60s (Table 1). BrainMRI showed cerebellar at-
rophy in all affected individuals for whom it was available
(Figures 2A and 2B). Analysis of genes previously associated
with SCA failed to detect mutations (data not shown), and
therefore we performed a whole-genome linkage analysis
on 65 individuals with the Affymetrix GeneChip Human
Mapping 10K Array Xba 142 2.0. Linkage analysis with
MERLIN showed maximum multipoint LOD scores of 5.1,
4.4, and 2.2 in chromosomal region 1p32 for families M,
R, and G, respectively (Figure 2C). Haplotype analysis in
these families established an 8 Mb candidate region con-
taining the disease mutation. Fine-mapping with 14 STRs
spanning this critical region positioned the mutation
between markers D1S200 and D1S2869, comprising
approximately 2.8 Mb on chr1: 56,010,121–58,760,479
(hg19) (Figure 1). This candidate region contained the
genes PPAP2B, PRKAA2, C1orf168, C8A, C8B, and DAB1
(Figure 2D) and overlapped the SCA37 locus mapped in
a Spanish family affected by pure SCA, which began in
most affected individuals as falls, dysarthria, or clumsiness
followed by a complete cerebellar syndrome.20A Rare Haplotype in 1p32.2 Is Shared by Affected
Individuals
We carried out mutation screening of candidate genes first
by Sanger sequencing of known exons and corresponding
exon-intron boundaries and then by NGS of the entire14 markers from locus D1S427 (51,245,557 bp) to D1S1577 (59,958,
initial candidate region spanning 2.8 Mb between markers D1S200
box). Symbols in pedigrees were modified for privacy protection. Ab
for whom DNA was available.
The Acandidate region in affected individuals and unaffected rel-
atives. In affected subjects, we detected 20 heterozygous in-
tergenic and intronic variantsnot found inhealthy relatives
and absent from or with a frequency below 1% in the 1000
Genomes Project and dbSNP (Table S3). None of the identi-
fied variants was located in exonic or consensus splicing
regions. We then carried out genotype analysis of variants
with a frequency lower than 0.1% in 150 families affected
by autosomal-dominant SCA of unknown genetic type
(34 of whom were from southern Portugal) and in the gen-
eral Portuguese population.We found three additional ped-
igrees sharing a core disease haplotypewith the three linked
families and confirmed that these variants were very rare in
the control population. All six families with the disease
haplotype were from southern Portugal. We identified
fourdifferenthaplotypes around the corehaplotype in fam-
ilies affected by this SCA (Table 2). Haplotype analysis in
the additional affected individuals narrowed the candidate
region down to 1.8 Mb from rs537634498 to marker
D1S2869. We then performed multiplex ligation-depen-
dent probe amplification on genes that are within this
region and are expressed in brain tissue, namely PPAP2B
(MIM: 607125), PRKAA2 (MIM: 600497), and DAB1, but
we detected no copy-number variations (data not shown).
An (ATTTC)n Insertion in DAB1 Segregates with SCA
Next, we used standard PCR to screen 278 repetitive
sequences within the candidate region containing tri-,
tetra-, penta-, hexa-, and heptanucleotide and other
complex repeats (Table S2 and Figure 2E). PCR analysis of
a pentanucleotide repeat (ATTTT/AAAAT) in the 50 UTR
intron 3 of DAB1 (GenBank: NM_021080) showed no
apparent transmission of this pentanucleotide repeat
(Figure 2E and Figure S1A). We consistently observed a
missing PCR product in all affected parent-to-affected-
offspring transmissions analyzed (Figure S1A) and hypoth-
esized that this most likely resulted from the presence of
large alleles that were not amplifiable under standard
PCR conditions. To investigate this further, we performed
Southern blot analysis and identified an approximately
5.1 kb band that was transmitted only from affected
individuals to their affected offspring (Figure 2F and
Figure S1B). The amplification of these large alleles by
long-range PCR of the repetitive region, followed by direct
sequencing, enabled us to find a heterozygous (ATTTC)n
insertion within the simple ATTTT/AAAAT repeat at
nucleotide 57,832,716 on chromosome 1 (hg19). We
identified complex pentanucleotide repeats with the struc-
ture [(ATTTT)60–79(ATTTC)31–75(ATTTT)58–90] in 3
0 fully
sequenced alleles (Figures 1 and 3A–3C and Table S4). We
confirmed the presence of this (ATTTC)n insertion with
its flanking (ATTTT)n by Sanger sequencing analysis in all568). The disease haplotypes found in the families established an
and D1S2869 in chromosomal region 1p32.2 (hg19) (shown in a
breviations are as follows: n.d., not determined; and þ, individual
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Table 1. Clinical and Genetic Features of Selected Affected Individuals
Family Affected Individual Gender Onset Age (Years) Disease Progression (Years) Onset Symptoms Ataxia (ATTTC)n
a
M M1 F 30 34 DA þþþ 60
M2 M 30 40 DA NA 67
M3 F 18 24 DA NA 75
M4 F 32 3 DA NA 74
M5 F 30 27 DA þþ 53
M6 F 34 6 DA þþ 62
M7 F 40 6 DA þþ 60
M8 M 27 30 GI þþþ 73
M9 F 23 38 DA, GI þþ 54
M10 F 46 6 DA, GI þ 60
M11 M 30 8 DA, GI þ 61
M12 F 26 15 DA, GI þþ 60
M13 F 29 2 DA þ 65
G G2 F 58 10 DA, GI þþ 43
G6 F 55 20 GI þþ 31
G8 F 40 14 DA þþ 51
G9 M 45 13 DA þþ 53
G11 F 35 2 DA þ 50
R R1 F 30 47 DA þþ 56
R2 F 40 29 DA þþ 52
R3 F 31 47 DA þþ 57
R4 M 55 14 DA þþ 59
R5 F 28 12 DA þ 71
R6 F 30 5 DA þ 71
R7 M 32 5 DA þ 69
R8 F 23 54 DA þþþ 55
MS MS1 M 40 38 DA, GI þþþ 46
MS2 M 47 31 GI þþþ 52
MS3 M 57 14 DA, GI þþþ 46
MS4 F 31 6 DA þþ 61
Abbreviations are as follows: DA, dysarthria; GI, gait imbalance; and NA, not available.
aThe ATTTC repeat insertion is always flanked on both sides by (ATTTT)>58.35 affected individuals from the initial three large kindreds
and in the six available affected subjects from the three
additional pedigrees with the shared core haplotype
(Figure 1 and Table S4). The heterozygous (ATTTC)n inser-
tion, ranging from 31 to 75 repeats (Figure 4A), was always
flanked by (ATTTT)n tracts larger than 58 repeats and could
be detected by repeat-primed PCR (Figure 3D). This
(ATTTC)n insertion segregated with the disease in all fam-
ilies and was not detected by sequencing analysis of 520
chromosomes from the normal Portuguese population.
In every disease allele, the insertion site was identical and
placed in the middle of the normal ATTTT repeat, thus92 The American Journal of Human Genetics 101, 87–103, July 6, 201maintaining the pentanucleotide repeat structure. This ge-
netic evidence establishes the (ATTTC)n insertion in DAB1
as causative for this type of autosomal-dominant SCA.
Normal Polymorphic ATTTT Alleles Are Rarely Very
Large
The ATTTT/AAAAT repeat localizes to the polymorphic
middle A-rich region of an AluJb sequence (Figure 3A). Af-
ter sequencing analysis in 260 subjects from the normal
population, we found normal alleles of 7–400 ATTTT/
AAAAT repeat tracts that never contained the pathological
ATTTC repeat insertion (Figure 4B). We also performed7
A B C
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Figure 2. Chromosome Mapping and
Mutation Screening
(A and B) Brain MRI of affected individual
M8 (Table 1) shows atrophy of (A) the cere-
bellar cortex on sagittal T1 and (B) the
middle cerebellar peduncles on an axial
T2-weighted image.
(C) Linkage analysis using genotypes from
18 individuals from family M shows a
maximummultipoint LOD score of 5.1 ob-
tained in chromosomal region 1p32.
(D) Schematic physical map of the SCA
candidate region; also depicted are the in-
tronic repeat region with the XbaI restric-
tion sites, the location of the Southern
blot probe, and primers used for standard
PCR. The (ATTTT)n position according to
hg19 is shown.
(E) Standard PCR analysis of the pentanu-
cleotide repeat ATTTT/AAAAT in the in-
tronic 50 UTR of DAB1 shows a lack of
PCR amplification of large repeat tracts
that were not amplified by standard PCR.
(F) Using a probe hybridizing near the
pentanucleotide repeat ATTTT/AAAAT in
DAB1, corresponding Southern blot anal-
ysis for the same family branch in (E)
shows that an 5.1-kb fragment corre-
sponding to 200 pentanucleotide repeats
was transmitted from the affected mother
to affected offspring. Large non-patho-
genic (ATTTT)n alleles are unstable, and
the estimated allele size of 120 on South-
ern blot was shown by sequencing analysis
to vary from 127 to 139 units. Individual
ID numbers are the same as those in each
pedigree in Figure 1.sequencing analysis of a cohort of 452 subjects with neuro-
degenerative diseases of European and North American
origin, including 101 unrelated subjects presenting with
ataxia, tremor, or cognitive decline with onset after the
age of 50 years and no family history; we did not find
the (ATTTC)n insertion in these subjects, and the distribu-
tion of the ATTTT/AAAAT repeat allele was similar to that
in the normal population (Figure 4C). Overall, the distribu-
tion of normal ATTTT/AAAAT repeats comprised mostly
alleles shorter than 30 repeats and a rare group of larger
alleles ranging from 30 to 400 repeats (with a frequency
of 7.3% in the normal population and 6.7% in subjects
with neurodegenerative diseases).
Length of the Unstable (ATTTC)n Insertion Correlates
Inversely with Age of Onset
We observed a significant inverse correlation between
ATTTC insertion size and age of onset (Figure 5A) wherebyThe American Journal of Humaffected individuals with larger inser-
tion sizes presented with earlier onset
(r ¼ 0.68, p < 0.001, n ¼ 33). Thus,
the ATTTC insertion size explains
approximately 50% of variation in
the age of disease onset (R2 ¼ 0.46).
Analysis of the ATTTC repeat insertion in families showed
instability upon transmission in 81% (13/16) of parent-
offspring transmissions (Figure 5B). The repeat insertion
increased in length in all paternal transmissions by 2–12
ATTTCs but in only 67% (6/9) of maternal transmissions
by two to seven ATTTC repeats. Figure 5C shows the differ-
ence in (ATTTC)n insertion size inheritedbypairs of siblings
from paternal and maternal transmissions. In sibships,
paternal transmissions led to inherited repeat insertions
varying by 0–19 units, whereas the difference was of 1–6
ATTTCsuponmaternal transmissions. These results suggest
that the (ATTTC)n insertion is highly unstable, even more
so when the father is the transmitting parent.
Cerebellar Expression of DAB1 Transcripts with the
(ATTTC)n Insertion Intron
In theDAB1-oriented strand, the ATTTC repeat insertion is
located in a 50 UTR intron. DAB1 encompasses a region ofan Genetics 101, 87–103, July 6, 2017 93
Table 2. Refinement of the Candidate Region
Gene or Intergenic Region Marker Position on Chr1 (hg19)
Haplotypes
A B C D
Intergenic rs565332393 56,090,535 C C T T
rs762335464 56,223,397 C C T T
rs142969184 56,251,658 A A C C
rs761751006 56,305,070 G G A A
ss2137493855 56,453,113 G G A A
D1S2742 56,693,429 3 3 4 2
rs777060331 56,517,710 C C T T
ss2137493856 56,545,567 G G A A
rs138928773 56,753,932 C C T T
rs528859858 56,810,200 A A A G
PPAP2B rs537634498 56,964,113 CCCAGC CCCAGC CCCAGC delCCCAGC
PRKAA2 D1S2690 57,155,539 2 2 2 2
C1orf168 rs555296478 57,250,815 delT delT delT delT
C8A rs572272180 57,367,559 delTTG delTTG delTTG delTTG
Intergenic rs115293800 57,438,757 C C C C
rs866411539 57,444,772 T T T T
DAB1 rs145962085 57,481,145 C C C C
ss2137493861 57,491,966 G G G G
D1S2867 57,608,090 2 2 2 2
D1S2665 57,693,122 5 5 5 5
(ATTTC)n 57,832,716 (ATTTC)n (ATTTC)n (ATTTC)n (ATTTC)n
D1S2890 57,873,400 1 1 1 1
ss2137493857 57,551,605 A A A A
rs192485043 57,926,567 A A A A
rs145097803 58,201,704 A A A A
ss2137493862 58,215,160 G G G G
D1S476 58,238,915 4 4 4 4
Intergenic D1S2869 58,760,479 5 1 ND ND
The following abbreviation is used: ND, not determined.1.25 Mb genomic DNA. The 50 UTR is composed of very
large introns and spreads over 961 kb.28 At the expression
level, the gene is very complex in that it contains several
alternative first exons, which can result in transcripts
with variable 50 UTRs. The largest known coding transcript
(Ensembl: ENST00000371236) comprises 15 exons and en-
codes a 5,298-bp mRNA and a 555-aa protein. Two vali-
dated DAB1 transcripts have exons flanking the repeat
insertion site, and both encode a known 555-aa protein,
represented in Figure 6A as V1 and V2. Additionally, two
other transcripts found in the UCSC Genome Browser
(hg19) and/or Ensembl position the (ATTTC)n insertion re-
gion in 50 UTR introns. These are variants V3, encoding a
predicted 213-aa protein, and V4 encoding a known pro-94 The American Journal of Human Genetics 101, 87–103, July 6, 201tein of 555 residues (Figure 6A). We confirmed the expres-
sion of transcripts encompassing the intronic repeat inser-
tion region by full-length RT-PCR of total human cerebellar
RNA (Figure S2). We also analyzed the data obtained by cap
analysis of gene expression (CAGE) from the FANTOM5
promoterome project29 and compared the expression of
these transcripts in multiple human CNS regions, skin
fibroblasts, and lymphoblastoid cell lines (Figure 6B). In
human adults, the transcript variants DAB1 V1 and V3
were highly expressed in the cerebellum and modestly ex-
pressed in the hippocampus, the reverse of which was true
for variant V2. The transcript variants V1, V3, and V4
showed low levels of expression in CNS regions except
for the cerebellum and pineal gland, where they showed7
AB
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Figure 3. Identification of an Unstable ATTTC Repeat Insertion in DAB1
(A) Schematic representation of the ATTTT/AAAATsimple repeat flanked by left (LM) and right (RM)monomers in the polymorphicmid-
dle A-rich region of an AluJb sequence in an intron of the DAB1 50 UTR; also depicted is the structure of normal alleles (NAs) with pure
ATTTT/AAAAT repeats and mutant alleles (MAs) with the (ATTTC)n insertion.
(B) Sequencing analysis of the DAB1 repeat shows the (ATTTC)n insertion in the middle of the ATTTT simple repeat in affected
individuals.
(C) Long-range PCR across the Alu sequence was used for assaying alleles up to 2.7 kb.
(D) In this family branch shown for long-range PCR, the ATTTC repeat insertion was readily detected by RP-PCR analysis in affected
individuals (mother I.2 and offspring II.1 and II.2) but not in the unaffected individuals I.1 and II.3.high levels. The expression of DAB1 was mainly brain spe-
cific, and lymphoblastoid cells and fibroblasts showed very
low levels of each transcript. All transcript variants showed
much higher expression in human fetal brain tissue than
in adult brains (Figure 6C). During development of the
mouse cerebellum, Dab1 expression is tightly regulated
from embryonic day 11 to postnatal day 9, as shown by
analysis of the data from FANTOM5 (Figure 6D),30 which
is in line with its known essential function in the forma-
tion of this brain structure. DAB1 is a reelin signal trans-
ducer responsible for the accurate neuronal positioning
of cerebellar, hippocampal, and cortical neurons duringThe Adevelopment.31 DAB1 function relies on an N-terminal
PID/PTB (protein interaction/phosphotyrosine binding)
domain involved in reelin receptor binding. Importantly,
all four transcript variants spanning the repeat insertion
region, including those abundantly expressed in the
adult cerebellum, encode the functional PID/PTB domain
(Figure 6A). Concomitant with the transcriptional data
analysis, we found that DAB1 was present in human adult
and mouse cerebellum, whereas no protein could be de-
tected in primary skin fibroblasts in these experimental
conditions or with an antibody against the C terminus of
DAB1 (Figure 6E).merican Journal of Human Genetics 101, 87–103, July 6, 2017 95
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Figure 4. Distribution of Pathological and Normal Alleles
(A) The absolute frequency of pathological (ATTTC)n allele sizes in
SCA subjects (n ¼ 41).
(B and C) Distribution of (ATTTT)n allele sizes in chromosomes
from (B) the normal population (n¼ 520) and (C) affected individ-
uals with other neurodegenerative diseases (n ¼ 904).
A
B
C
Figure 5. Inverse Correlation between (ATTTC)n Size and Age
of Onset in SCA Subjects and Instability
(A) A scatterplot showing an inverse correlation between the
length of the (ATTTC)n insertion and age of onset. Affected
individuals with larger insertion sizes present with earlier onset
(r ¼ 0.68, p < 0.001, n ¼ 33).
(B) Parent-offspring transmissions with varying ATTTC repeat
numbers with paternal or maternal origin.
(C) Difference in ATTTC insertion size in pairs of siblings upon
paternal and maternal transmissions.RNA Aggregates in Human Cells Overexpressing the
(ATTTC)n Insertion
A plethora of different pathogenic mechanisms have
been associated with neurodegeneration caused by repeat
expansion in the non-coding region of genes. Formation
of abnormal secondary structures by transcripts harboring
repeat expansions leading to aberrant nuclear RNA aggre-
gation is a common feature of these neurodegenerative dis-
eases.32 RNA aggregates have been extensively described
in affected tissues and can be observed upon overexpres-
sion of repeat-containing RNAs in cell models or organ-
isms, even if they are removed from their normal gene
context.9 To assess whether the ATTTC repeat insertion
in DAB1 causes the formation of RNA aggregates, we over-
expressed it in the human embryonic cell line HEK293T.
Using a (TGAAA)5TGA probe predicted to hybridize to
(AUUUC)n, we detected widespread formation of RNA ag-
gregates by FISH 48 hr after transfection of a plasmid con-
taining the repeat insertion with its flanking ATTTTs and
AluJb monomers, ins(ATTTC)58, whereas none were de-
tected in cells transfected with the corresponding normal96 The American Journal of Human Genetics 101, 87–103, July 6, 201N(ATTTT)7 or N(ATTTT)139 sequence (Figure 7A). These
RNA aggregates generally had a nuclear localization
(Figure 7B). Enzymatic treatment of the cells with RNase,
but not with DNase, led to the disappearance of the FISH
signal, suggesting that the labeled probe was hybridizing
specifically to RNA (Figure 7C).
(AUUUC)n-Containing RNA Impairs Early Embryonic
Development
To investigate whether the (ATTTC)n repeat insertion is
deleterious in vivo, we injected 1- to 2-cell-stage zebrafish
embryos with RNA containing the pathological DAB1
repeat insertion with its flanking AUUUUs and AluJb
monomers and assessed animal viability, morphology,
and survival. We injected RNA obtained from the normal7
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Figure 6. Expression of DAB1 Transcripts Spanning the Region Containing the Repeat Insertion and DAB1
(A) Schematics of DAB1 genomic position on chromosome 1 show transcripts identified by CAGE (FAMTOM5) to result from usage of
alternative promoters. These transcripts are also annotated in Ensembl or the UCSC Genome Browser (hg19), and all have the repeat
insertion region in the 50 UTR. Coding and non-coding exons in transcripts are represented by closed and open boxes, respectively.
The location of the (ATTTC)n insertion region in transcript variants is represented by a diamond and indicated with an arrow, and
the locations of the ATG start codon and TAG stop codon are shown. The following abbreviation is used: PID, phosphotyrosine inter-
action domain.
(B–D) Mean expression levels of DAB1 transcripts in different CNS regions, skin fibroblasts, and B lymphoblastoid cells from human
adults, as analyzed from CAGE data (B);29 mean expression levels of DAB1 transcript variants in CNS regions of 20- to 29-week-old hu-
man fetuses (C); and mean developmental expression levels of Dab1 transcripts in mouse cerebellum from embryonic day 11 (E11) to
(legend continued on next page)
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alleles N(ATTTT)7 and N(ATTTT)139 and from the patho-
logical ins(ATTTC)58. At 24 hpf, the lethality rate detected
in the embryos injected with ins(AUUUC)58 was signifi-
cantly higher than in the other conditions (21.51%
for control RNA, 18.51% for N(AUUUU)7, 14.40% for
N(AUUUU)139, and 58.79% for ins(AUUUC)58; average of
three replicas with at least 200 embryos per replica; c2
test p% 0.001; Figure 8A). This difference was even higher
among phenotypes in the surviving embryos, showing
that the number of embryos that developed normally in
the ins(AUUUC)58 injection was significantly lower than
in the other conditions (77.52% for control RNA, 79.79%
for N(AUUUU)7, 85.37% for N(AUUUU)139, and 7.76%
for ins(AUUUC)58; c
2 test p < 0.0001; Figure 8A).
Figure 8B shows the distribution of phenotypic classes
observed in embryos injected with ins(AUUUC)58. These
results further suggest that theDAB1 repeat insertion iden-
tified in this SCA is potentially deleterious in vivo.Discussion
We report the identification of an autosomal-dominant
SCA characterized by pure cerebellar ataxia, as well as
dysarthria as the first clinical manifestation, and caused
by an insertion of an unstable ATTTC repeat in the non-
coding region of the neurodevelopmental DAB1, which
locates to the mapped SCA37 locus. The mutation consists
of an insertion of an ATTTC repeat in the middle of an
(ATTTT)n tract. The (ATTTC)n insertion (ranging from 31
to 75 pure ATTTC units) was found in affected individuals
and absent from 520 control chromosomes. It completely
segregates with the disease in the six families studied. The
DAB1 mutation leads to an aberrant behavior of RNAs
containing the AUUUC repeat insertion, rendering them
prone to aggregation in a human cell line. In vivo assess-
ment of the pathogenicity of this DAB1 insertion suggests
that this abnormal RNA is toxic to zebrafish embryos by
causing developmental defects and increased lethality.
The systematic epidemiological survey of hereditary
ataxias performed in Portugal has allowed the genetic char-
acterization of a large number of families.3 All affected
subjects with this genetic type of SCA are originally from
southern Portugal. It is interesting to notice that whereas
MJD (SCA3) is the most frequent in the archipelago of
Azores and in northern and central mainland Portugal, it
is rarely found in the south.3 In the southern provinces
of the country, the SCA described here is the most com-
mon by representing 14% of autosomal-dominant forms.postnatal day 9 (P9), as analyzed from CAGE data (D).30 Samples avai
from one to three in human adults and fromone to two in human fetu
all stages. Data represent the mean5 SD.
(E) Western blot analysis of DAB1 localization in adult human and
HEK293T cells overexpressing human DAB1 cDNA plasmid (pCMV6
cate cropped areas from digital images of the same membrane obtain
the other three lanes).
98 The American Journal of Human Genetics 101, 87–103, July 6, 201It is remarkable that an (ATTTC)n of 31–75 units is
disease causing, whereas an (ATTTT)n of much larger size
that can reach 400 repeats is not pathogenic. The (ATTTT)n
length in healthy individuals ranged from 7–400 pentanu-
cleotide units, whereas the ATTTT repeat tracts that flank
the (ATTTC)n insertion in affected individuals from this
study were larger than 58 units. The total pentanucleotide
repeat size for the complex (ATTTT)n(ATTTC)n(ATTTT)n
assessed in this cohort varied from approximately 190 to
220 units. For these sizes, RP-PCR can efficiently detect
the repeat insertion in the middle of this complex repeat,
but larger flanking (ATTTT)n sizes would not allow RP-
PCR insertion detection; sequencing is required for confir-
mation of its presence.
We observed significant intergenerational instability of
the (ATTTC)n insertion, a feature common tomost diseases
involving repeat expansions.8,33 This repeat insertion is
more unstable when the father is the transmitting parent,
when its size tends to be larger than in maternal transmis-
sions. This suggests that meiotic instability could play
a relevant role in this dynamic feature, but we cannot
exclude the possibility that mitotic instability during
development and aging causes somatic mosaicism in the
affected brain regions.
Notably, this cohort shows an inverse correlation be-
tween age of disease onset and size of the (ATTTC)n
insertion, such that larger repeats result in earlier clinical
manifestation, a feature of many disorders of repeat ex-
pansions. In fact, the size of the repeat insertion accounts
for approximately 50% of the variability in age of onset
(from late adolescence to the early 60s). Interestingly,
recent evidence from a mouse model of SCA1 points to
the existence of neuronal dysfunction, from development
to adulthood, preceding the appearance of the neurolog-
ical symptoms and neuronal cell death.34 Here, we identi-
fied a SCA-causing mutation in a neurodevelopmental
gene, raising the possibility that neuronal dysfunction
starting early in brain development could contribute to
disease pathogenesis.
The expression of DAB1 is tightly regulated during
development and across various brain regions. In the hu-
man CNS, expression analysis showed alternative pro-
moter usage for DAB1 and region-specific expression of
different transcripts. The (ATTTC)n insertion region re-
ported here is included in all four transcripts identified
in the human brain. Three of them encode the same
protein of 555 residues (V1, V2, and V4) but differ in
their 50 UTRs. The promoter of transcript V2 is the most
widely used in the CNS, whereas the promoters for V1,lable for expression analysis of each CNS region or cell type ranged
ses, whereas inmouse cerebellum, three samples were available for
mouse cerebellum and in primary skin fibroblasts. DAB1 from
-hDAB1, OriGene Technologies) was used as a control. Boxes indi-
ed at different exposure times (30 s for the first lane and 5 min for
7
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Figure 7. Formation of (AUUUC)n RNA Aggregates in a Human Cell Line
(A) Two normal Alu fragments with a simple ATTTT repeat of different size and the pathogenic ATTTC repeat insert (with the configu-
ration (ATTTT)57(ATTTC)58(ATTTT)73) were directly amplified from genomic DNA and cloned into the pCDH-CMV-EF1-GFP-Puro
vector.
(legend continued on next page)
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V3, and V4 are less used in general, except in the
cerebellum. Altogether, this suggests that transcriptional
regulation most likely plays an important role in tuning
DAB1 function, especially in the cerebellum, the brain
structure most affected in this SCA. Future studies will
address to what extent the ATTTC repeat insertion in
the non-coding DAB1 could alter its expression and
normal function.
Given that injection of AUUUC repeat RNA into 1-cell-
stage zebrafish embryos led to lethal developmental
malformations causing significant death, we hypothesize
that an RNA-mediated mechanism could contribute to
the pathogenesis of this SCA. This RNA-mediated lethality
seen in zebrafish embryos might be initiated by different,
non-mutually exclusive mechanisms. Considering also
that overexpression of the ATTTC repeat insertion leads
to the formation of nuclear RNA aggregates in human
cell lines, and in light of what we learned from other dis-
eases involving non-coding repeats, these aberrant RNAs
can be pathogenic by (1) sequestering critical RNA-binding
proteins and preventing them from performing their
normal function,32 (2) initiating non-AUG-dependent
translation and producing toxic peptides,19,35 and (3) dis-
rupting RNA metabolism processes such as splicing or
nuclear export.8 A possible pathological contribution of
bidirectional transcription across the repeat insertion
region, described in several repeat diseases,8,15 remains to
be investigated.
This form of cerebellum-specific degeneration is caused
by a repeat insertion in DAB1, which encodes an adaptor
protein of the reelin signaling pathway that controls
neuronal migration and maturation of synaptic connec-
tions in the brain during development.36 Homozygous
mutations in mouse Dab1 cause the scrambler and yotari
phenotypes, characterized by aberrant splicing forms of
Dab1 transcripts and little or no DAB1, leading to wide-
spread misplacement of neurons in the cerebellum, hip-
pocampus, and cortex and the associated ataxia.31,36,37
In young-adult mouse hippocampus, the reelin-DAB1
pathway regulates the maturation of dendritic spines, syn-
aptogenesis, and glial ensheathment of newborn granule
cells.38 In humans, a homozygous deletion of VLDLR
(MIM: 192977), which encodes a receptor for reelin, origi-
nates an autosomal-recessive nonprogressive cerebellar
ataxia and mental impairment (MIM: 224050).39 The pres-
ence of cerebellar symptoms is a common feature when
the reelin-DAB1 pathway is impaired; however, the cere-
bellar atrophy exhibited by the affected individuals in
this study is very mild in comparison with the recessive
phenotypes referred above.(B) Transient overexpression of the pathogenic ATTTC repeat insertio
cells leads to widespread formation of nuclear RNA aggregates visib
hybridize to (AUUUC)n. GFP expression was used as a marker for
bars, 5 mm.
(C) Aggregates, variable in size and number in individual cells, were s
sentative images are projections of z stacked images collected at 0.21
100 The American Journal of Human Genetics 101, 87–103, July 6, 20It is interesting that the (ATTTC)31–75 insertion in the
intronic 50 UTR of DAB1 is structurally similar to the
SCA10-causing (ATTCT)800–4,500 expansion in intron 9
of ATXN10.16 The size ranges of the pathological penta-
nucleotide repeats for fully penetrant alleles differ
greatly between these two diseases. One can speculate
that these different size requirements for pathology are
related to the specific gene context and localization in
genomic elements.40 Nevertheless, given the bias to-
ward increased (ATTTC)n size upon transmission, larger
alleles might be expected to appear in affected individ-
uals from other families with this repeat insertion.
Notably, alleles of 280–850 units show reduced pene-
trance in SCA10, and alleles of 33–280 repeats have
not been observed.41–43
DAB1 lies within the mapped SCA37 locus in chromo-
somal region 1p32 in a family originating from Spain.20
The occurrence of multiple SCA gene mutations clustered
in small genomic regions is rare and has been seen only
in PDYN (MIM: 131340; associated with SCA23 [MIM:
610245]), NOP56 (associated with SCA36), and TGM6
(MIM: 613900; associated with SCA35 [MIM: 613908]),
which are contained in a 750 kb region on human chromo-
somal arm 20p.12,44,45 DAB1 encompasses 1.25 Mb within
the SCA37 locus, and there is a possibility that the same
ATTTC repeat insertion described here is the mutation
in the SCA37-affected family, especially given that this
kindred is from Spain, a country that borders Portugal.
Thus, it is possible that the high incidence of DAB1 repeat
insertions found in Portuguese SCA subjects could extend
to Spain and probably other populations of European
ancestry.
The highly polymorphic (ATTTT)n where the ATTTC
insertion occurred is located in the middle A-rich stretch
of an AluJb element. Other repeat diseases, such as Frie-
drich ataxia (MIM: 229300), DM2, SCA10, and SCA31,
originate from the expansion or insertion of repeats
in poly-A tracts in the middle or 30 end of Alu ele-
ments.14,46–48 These A-rich tracts can be the basis for nucle-
otide substitution leading to microsatellite birth either
through errors introduced during Alu reverse transcription
or through the accumulation of mutations in Alu poly-A
stretches after insertion.40
This is the second neurodegenerative disease (in addition
to SCA31) caused by an insertion in a polymorphic repeat
located in an A-rich region of an Alu element.14 In both
cases, the insertion of the pathogenic repeat is flanked by
ATTTT/AAAAT tracts, creating a large unstable repeat that
shares similarities with expanded repeats. These unstable
repeat insertions might thus constitute a new class ofn, but not the normal ATTTT repeat of 7 or 139 units, in HEK293T
le after FISH staining with a probe, (TGAAA)5TGA, predicted to
transfection. Represented are single-plane confocal images. Scale
ensitive to enzymatic treatment with RNase but not DNase. Repre-
mm intervals with a confocal microscope. Scale bars, 5 mm.
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Figure 8. In Vivo Deleterious Effects of the (ATTTC)n Insertion
(A) Percentage of embryos that presented with lethality (dead),
developmental defects (defects), or a wild-type phenotype
(normal) at 24 hpf after RNA injection of control Cas9RNA,
N(AUUUU)7, N(AUUUU)139, or ins(AUUUC)58 (average of three
replicas with at least 200 embryos per replica; ***p % 0.001; c2
test for the lethality rate). Data represent the mean5 SD.
(B) Distribution of phenotypic classes (a–d) observed in in-
s(AUUUC)58-injected embryos at 24 hpf and representative images
of the observed phenotypic classes: (a) wild-type, (b) severe defects
in the tail and head, (c) mild defect in the tail, and (d) severe
defects in the anterior-posterior axis.dynamic mutations, difficult to identify with the common
strategies currently in use. Furthermore, its occurrence in
two genetic types of SCA suggests that they could be impli-
cated in other brain diseases of unknown molecular etiol-
ogy. The discovery of a pathogenic (ATTTC)n insertion in
DAB1 could contribute toward a better understanding of
neurodegenerative diseases.The AAccession Numbers
The accession numbers for the data reported in this paper
are ClinVar: SCV000579455 and dbSNP: ss2137493862,
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2017.06.007.Acknowledgments
We thank the families who participated in this study. We are
grateful to Gonc¸alo Abecasis, Miguel Costa, Tito Vieira, and
Andre´ Torres for help with MERLIN analysis; Beatriz Sobrino,
Jorge Amigo, and Pilar Cacheiro for next-generation sequencing
analysis, performed at the Santiago de Compostela node of the
Spanish National Genotyping Center; Nuno Santare´m and
Anabela Cordeiro-da-Silva for assistance with cloning; Anto´nio
Amorim, Laura Vilarinho, and Paula Jorge for samples from the
Portuguese population; and Paula Magalha˜es from the Institute
for Molecular and Cell Biology Cell Culture and Genotyping
Core for DNA extraction. This work was financed by Fundo
Europeu de Desenvolvimento Regional (FEDER) funds through
the COMPETE 2020 Operational Program for Competitiveness
and Internationalization (POCI) of Portugal 2020 and by Portu-
guese funds through the Fundac¸a˜o para a Cieˆncia e a Tecnologia
(FCT) and Ministe´rio da Cieˆncia, Tecnologia, e Inovac¸a˜o in the
framework of the project ‘‘Institute for Research and Innovation
in Health Sciences’’ (POCI-01-0145-FEDER-007274); and by
FCT grant PTDC/SAU-GMG/098305/2008 to I.S. A.I.S. was the
recipient of an FCT scholarship (SFRH/BD/30702/2006). J.R.L.
was supported by scholarships from PEst-C/SAU/LA0002/2013
and the European Molecular Biology Organization (ASTF494-
2015). C.L.O. was supported by a scholarship from PEst-C/
SAU/LA0002/2013. This work was also financed by the Porto
Neurosciences and Neurologic Disease Research Initiative at the
Instituto de Investigac¸a˜o e Inovac¸a˜o em Sau´de (Norte-01-0145-
FEDER-000008), supported by Norte Portugal Regional Opera-
tional Programme (NORTE 2020) under the PORTUGAL 2020
Partnership Agreement through FEDER, and by the Fondo de
Investigacio´n Sanitaria of the Instituto de Salud Carlos III (grant
PI12/00742).
Received: March 17, 2017
Accepted: June 13, 2017
Published: July 6, 2017Web Resources
1000 Genomes, http://www.1000genomes.org/
ClinVar, https://www.ncbi.nlm.nih.gov/clinvar/
dbSNP, http://www.ncbi.nlm.nih.gov/SNP/
Ensemble Genome Browser, http://www.ensembl.org/index.html
FANTOM, http://fantom.gsc.riken.jp/Zenbu/
GenBank, http://www.ncbi.nlm.nih.gov/genbank/
GenomeAnalysis Toolkit, http://www.broadinstitute.org/genome-
analysis-toolkit
OMIM, http://www.omim.org
UCSC Genome Browser, http://genome.ucsc.edu/merican Journal of Human Genetics 101, 87–103, July 6, 2017 101
References
1. Sequeiros, J., Martins, S., and Silveira, I. (2012). Epidemiology
and population genetics of degenerative ataxias. Handb. Clin.
Neurol. 103, 227–251.
2. Durr, A. (2010). Autosomal dominant cerebellar ataxias:
polyglutamine expansions and beyond. Lancet Neurol. 9,
885–894.
3. Coutinho, P., Ruano, L., Loureiro, J.L., Cruz, V.T., Barros, J.,
Tuna, A., Barbot, C., Guimara˜es, J., Alonso, I., Silveira, I., et al.
(2013). Hereditary ataxia and spastic paraplegia in Portugal: a
population-basedprevalence study. JAMANeurol.70, 746–755.
4. Silveira, I., Miranda, C., Guimara˜es, L., Moreira, M.C., Alonso,
I., Mendonc¸a, P., Ferro, A., Pinto-Basto, J., Coelho, J., Ferreiri-
nha, F., et al. (2002). Trinucleotide repeats in 202 families
with ataxia: a small expanded (CAG)n allele at the SCA17 lo-
cus. Arch. Neurol. 59, 623–629.
5. Carlson, K.M., Andresen, J.M., and Orr, H.T. (2009). Emerging
pathogenic pathways in the spinocerebellar ataxias. Curr.
Opin. Genet. Dev. 19, 247–253.
6. Coutelier, M., Blesneac, I., Monteil, A., Monin, M.L., Ando, K.,
Mundwiller, E., Brusco, A., Le Ber, I., Anheim, M., Castrioto,
A., et al. (2015). A Recurrent Mutation in CACNA1G Alters
Cav3.1 T-Type Calcium-Channel Conduction and Causes
Autosomal-Dominant Cerebellar Ataxia. Am. J. Hum. Genet.
97, 726–737.
7. Di Gregorio, E., Borroni, B., Giorgio, E., Lacerenza, D., Ferrero,
M., Lo Buono, N., Ragusa, N., Mancini, C., Gaussen, M., Cal-
cia, A., et al. (2014). ELOVL5 mutations cause spinocerebellar
ataxia 38. Am. J. Hum. Genet. 95, 209–217.
8. Loureiro, J.R., Oliveira, C.L., and Silveira, I. (2016). Unstable
repeat expansions in neurodegenerative diseases: nucleocyto-
plasmic transport emerges on the scene. Neurobiol. Aging 39,
174–183.
9. Mankodi, A., Logigian, E., Callahan, L., McClain, C., White,
R., Henderson, D., Krym,M., and Thornton, C.A. (2000). Myo-
tonic dystrophy in transgenic mice expressing an expanded
CUG repeat. Science 289, 1769–1773.
10. La Spada, A.R., and Taylor, J.P. (2010). Repeat expansion dis-
ease: progress and puzzles in disease pathogenesis. Nat. Rev.
Genet. 11, 247–258.
11. Wojciechowska, M., and Krzyzosiak, W.J. (2011). Cellular
toxicity of expanded RNA repeats: focus on RNA foci. Hum.
Mol. Genet. 20, 3811–3821.
12. Kobayashi, H., Abe, K., Matsuura, T., Ikeda, Y., Hitomi, T., Ake-
chi, Y., Habu, T., Liu, W., Okuda, H., and Koizumi, A. (2011).
Expansion of intronic GGCCTG hexanucleotide repeat in
NOP56 causes SCA36, a type of spinocerebellar ataxia accom-
panied bymotor neuron involvement. Am. J. Hum. Genet. 89,
121–130.
13. Garcı´a-Murias, M., Quinta´ns, B., Arias, M., Seixas, A.I.,
Cacheiro, P., Tarrı´o, R., Pardo, J., Milla´n, M.J., Arias-Rivas, S.,
Blanco-Arias, P., et al. (2012). ‘Costa da Morte’ ataxia is spino-
cerebellar ataxia 36: clinical and genetic characterization.
Brain 135, 1423–1435.
14. Sato, N., Amino, T., Kobayashi, K., Asakawa, S., Ishiguro, T.,
Tsunemi, T., Takahashi, M., Matsuura, T., Flanigan, K.M., Iwa-
saki, S., et al. (2009). Spinocerebellar ataxia type 31 is associ-
ated with ‘‘inserted’’ penta-nucleotide repeats containing
(TGGAA)n. Am. J. Hum. Genet. 85, 544–557.
15. Moseley, M.L., Zu, T., Ikeda, Y., Gao, W., Mosemiller, A.K.,
Daughters, R.S., Chen, G., Weatherspoon, M.R., Clark, H.B.,102 The American Journal of Human Genetics 101, 87–103, July 6, 20Ebner, T.J., et al. (2006). Bidirectional expression of CUG
and CAG expansion transcripts and intranuclear polyglut-
amine inclusions in spinocerebellar ataxia type 8. Nat. Genet.
38, 758–769.
16. Matsuura, T., Yamagata, T., Burgess, D.L., Rasmussen, A.,
Grewal, R.P., Watase, K., Khajavi, M., McCall, A.E., Davis,
C.F., Zu, L., et al. (2000). Large expansion of the ATTCT
pentanucleotide repeat in spinocerebellar ataxia type 10.
Nat. Genet. 26, 191–194.
17. Cleary, J.D., and Ranum, L.P. (2017). New developments in
RAN translation: insights from multiple diseases. Curr. Opin.
Genet. Dev. 44, 125–134.
18. Pearson, C.E. (2011). Repeat associated non-ATG translation
initiation: one DNA, two transcripts, seven reading frames,
potentially nine toxic entities!. PLoS Genet. 7, e1002018.
19. Ishiguro, T., Sato, N., Ueyama, M., Fujikake, N., Sellier, C.,
Kanegami, A., Tokuda, E., Zamiri, B., Gall-Duncan, T., Mirceta,
M., et al. (2017). Regulatory Role of RNA Chaperone TDP-43
for RNA Misfolding and Repeat-Associated Translation in
SCA31. Neuron 94, 108–124.e7.
20. Serrano-Munuera, C., Corral-Juan, M., Stevanin, G., San Nico-
la´s, H., Roig, C., Corral, J., Campos, B., de Jorge, L., Morcillo-
Sua´rez, C., Navarro, A., et al. (2013). New subtype of spinocer-
ebellar ataxia with altered vertical eye movements mapping to
chromosome 1p32. JAMA Neurol. 70, 764–771.
21. Ru¨schendorf, F., and Nu¨rnberg, P. (2005). ALOHOMORA:
a tool for linkage analysis using 10K SNP array data. Bioinfor-
matics 21, 2123–2125.
22. Wigginton, J.E., and Abecasis, G.R. (2005). PEDSTATS: descrip-
tive statistics, graphics and quality assessment for gene map-
ping data. Bioinformatics 21, 3445–3447.
23. Abecasis, G.R., Cherny, S.S., Cookson, W.O., and Cardon, L.R.
(2002). Merlin–rapid analysis of dense genetic maps using
sparse gene flow trees. Nat. Genet. 30, 97–101.
24. McKenna, A., Hanna, M., Banks, E., Sivachenko, A.,
Cibulskis, K., Kernytsky, A., Garimella, K., Altshuler, D.,
Gabriel, S., Daly, M., and DePristo, M.A. (2010). The
Genome Analysis Toolkit: a MapReduce framework for
analyzing next-generation DNA sequencing data. Genome
Res. 20, 1297–1303.
25. Schindelin, J., Arganda-Carreras, I., Frise, E., Kaynig, V., Long-
air, M., Pietzsch, T., Preibisch, S., Rueden, C., Saalfeld, S.,
Schmid, B., et al. (2012). Fiji: an open-source platform for bio-
logical-image analysis. Nat. Methods 9, 676–682.
26. Hwang, W.Y., Fu, Y., Reyon, D., Maeder, M.L., Tsai, S.Q.,
Sander, J.D., Peterson, R.T., Yeh, J.R., and Joung, J.K. (2013).
Efficient genome editing in zebrafish using a CRISPR-Cas sys-
tem. Nat. Biotechnol. 31, 227–229.
27. Mitsuhashi, H., Mitsuhashi, S., Lynn-Jones, T., Kawahara, G.,
and Kunkel, L.M. (2013). Expression of DUX4 in zebrafish
development recapitulates facioscapulohumeral muscular
dystrophy. Hum. Mol. Genet. 22, 568–577.
28. Bar, I., Tissir, F., Lambert de Rouvroit, C., De Backer, O., and
Goffinet, A.M. (2003). The gene encoding disabled-1
(DAB1), the intracellular adaptor of the Reelin pathway,
reveals unusual complexity in human and mouse. J. Biol.
Chem. 278, 5802–5812.
29. Forrest, A.R., Kawaji, H., Rehli, M., Baillie, J.K., de Hoon, M.J.,
Haberle, V., Lassmann, T., Kulakovskiy, I.V., Lizio, M., Itoh,M.,
et al.; FANTOM Consortium and the RIKEN PMI and CLST
(DGT) (2014). A promoter-level mammalian expression atlas.
Nature 507, 462–470.17
30. Arner, E., Daub, C.O., Vitting-Seerup, K., Andersson, R., Lilje,
B., Drabløs, F., Lennartsson, A., Ro¨nnerblad, M., Hrydziuszko,
O., Vitezic, M., et al.; FANTOM Consortium (2015). Tran-
scribed enhancers lead waves of coordinated transcription in
transitioning mammalian cells. Science 347, 1010–1014.
31. Howell, B.W., Gertler, F.B., and Cooper, J.A. (1997). Mouse
disabled (mDab1): a Src binding protein implicated in
neuronal development. EMBO J. 16, 121–132.
32. Todd, P.K., and Paulson, H.L. (2010). RNA-mediated neurode-
generation in repeat expansion disorders. Ann. Neurol. 67,
291–300.
33. Silveira, I., Alonso, I., Guimara˜es, L., Mendonc¸a, P., Santos, C.,
Maciel, P., Fidalgo De Matos, J.M., Costa, M., Barbot, C., Tuna,
A., et al. (2000). High germinal instability of the (CTG)n at the
SCA8 locus of both expanded and normal alleles. Am. J. Hum.
Genet. 66, 830–840.
34. Hatanaka, Y., Watase, K., Wada, K., and Nagai, Y. (2015).
Abnormalities in synaptic dynamics during development in
a mouse model of spinocerebellar ataxia type 1. Sci. Rep. 5,
16102.
35. Zu, T., Gibbens, B., Doty, N.S., Gomes-Pereira, M., Huguet, A.,
Stone, M.D., Margolis, J., Peterson, M., Markowski, T.W.,
Ingram, M.A., et al. (2011). Non-ATG-initiated translation
directed by microsatellite expansions. Proc. Natl. Acad. Sci.
USA 108, 260–265.
36. Sheldon,M., Rice, D.S., D’Arcangelo, G., Yoneshima, H., Naka-
jima, K., Mikoshiba, K., Howell, B.W., Cooper, J.A., Goldowitz,
D., and Curran, T. (1997). Scrambler and yotari disrupt the
disabled gene and produce a reeler-like phenotype in mice.
Nature 389, 730–733.
37. Goldowitz, D., Cushing, R.C., Laywell, E., D’Arcangelo, G.,
Sheldon, M., Sweet, H.O., Davisson, M., Steindler, D., and
Curran, T. (1997). Cerebellar disorganization characteristic
of reeler in scrambler mutant mice despite presence of reelin.
J. Neurosci. 17, 8767–8777.
38. Bosch, C., Masachs, N., Exposito-Alonso, D., Martı´nez, A.,
Teixeira, C.M., Fernaud, I., Pujadas, L., Ulloa, F., Comella,
J.X., DeFelipe, J., et al. (2016). Reelin Regulates theMaturation
of Dendritic Spines, Synaptogenesis and Glial Ensheathment
of Newborn Granule Cells. Cereb. Cortex 26, 4282–4298.
39. Boycott, K.M., Flavelle, S., Bureau, A., Glass, H.C., Fujiwara,
T.M., Wirrell, E., Davey, K., Chudley, A.E., Scott, J.N., McLeod,
D.R., and Parboosingh, J.S. (2005). Homozygous deletion ofThe Athe very low density lipoprotein receptor gene causes auto-
somal recessive cerebellar hypoplasia with cerebral gyral
simplification. Am. J. Hum. Genet. 77, 477–483.
40. Kelkar, Y.D., Eckert, K.A., Chiaromonte, F., and Makova, K.D.
(2011). A matter of life or death: how microsatellites emerge
in and vanish from the human genome. Genome Res. 21,
2038–2048.
41. Alonso, I., Jardim, L.B., Artigalas, O., Saraiva-Pereira, M.L.,
Matsuura, T., Ashizawa, T., Sequeiros, J., and Silveira, I.
(2006). Reduced penetrance of intermediate size alleles in spi-
nocerebellar ataxia type 10. Neurology 66, 1602–1604.
42. Seixas, A.I., Maurer, M.H., Lin, M., Callahan, C., Ahuja, A.,
Matsuura, T., Ross, C.A., Hisama, F.M., Silveira, I., and Margo-
lis, R.L. (2005). FXTAS, SCA10, and SCA17 in American
patients with movement disorders. Am. J. Med. Genet. A.
136, 87–89.
43. Matsuura, T., Fang, P., Pearson, C.E., Jayakar, P., Ashizawa, T.,
Roa, B.B., and Nelson, D.L. (2006). Interruptions in the
expanded ATTCT repeat of spinocerebellar ataxia type 10:
repeat purity as a disease modifier? Am. J. Hum. Genet. 78,
125–129.
44. Bakalkin, G., Watanabe, H., Jezierska, J., Depoorter, C.,
Verschuuren-Bemelmans, C., Bazov, I., Artemenko, K.A.,
Yakovleva, T., Dooijes, D., Van de Warrenburg, B.P., et al.
(2010). Prodynorphinmutations cause the neurodegenerative
disorder spinocerebellar ataxia type 23. Am. J. Hum. Genet.
87, 593–603.
45. Wang, J.L., Yang, X., Xia, K., Hu, Z.M., Weng, L., Jin, X., Jiang,
H., Zhang, P., Shen, L., Guo, J.F., et al. (2010). TGM6 identified
as a novel causative gene of spinocerebellar ataxias using
exome sequencing. Brain 133, 3510–3518.
46. Clark, R.M., Dalgliesh, G.L., Endres, D., Gomez, M., Taylor, J.,
and Bidichandani, S.I. (2004). Expansion of GAA triplet re-
peats in the human genome: unique origin of the FRDAmuta-
tion at the center of an Alu. Genomics 83, 373–383.
47. Kurosaki, T., Matsuura, T., Ohno, K., and Ueda, S. (2009).
Alu-mediated acquisition of unstable ATTCT pentanucleotide
repeats in the human ATXN10 gene. Mol. Biol. Evol. 26,
2573–2579.
48. Kurosaki, T., Ueda, S., Ishida, T., Abe, K., Ohno, K., and Mat-
suura, T. (2012). The unstable CCTG repeat responsible for
myotonic dystrophy type 2 originates from an AluSx element
insertion into an early primate genome. PLoS ONE 7, e38379.merican Journal of Human Genetics 101, 87–103, July 6, 2017 103
